Ignite Creation Date:
2024-05-06 @ 6:18 PM
Last Modification Date:
2024-10-26 @ 2:45 PM
Study NCT ID:
NCT05618301
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2022-11-08
Brief Title:
Motixafortide and Natalizumab to Mobilize CD34 Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease SCD
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Organization Data
Organization:
Washington University School of Medicine
Class:
OTHER
Study ID:
202302190
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Washington University School of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Biogen | INDUSTRY |
| BioLineRx Ltd | INDUSTRY |